Photo from wikipedia
We investigated the off-patent biological market in Belgium from a policy maker’s perspective, in light of the Belgian pharmaceutical health system. The main barriers relate to a short-term budgetary focus,… Click to show full abstract
We investigated the off-patent biological market in Belgium from a policy maker’s perspective, in light of the Belgian pharmaceutical health system. The main barriers relate to a short-term budgetary focus, to the overwhelming innovator’s reach and to a concertation model with assessment and appraisal being mixed which results in poorly effective policy measures.
Keywords:
patent biological;
market belgium;
market;
biological market;
health system
Journal Title: Pharmaceuticals
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pharmaceuticals
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!